US 7,388,089 B2 | ||
Anti-arthropod vector vaccines method of selecting and uses thereof | ||
Jesus G. Valenzuela, Rockville, Md. (US); Yasmine Belkaid, Norwood, Ohio (US); Shaden Kamhawi, Rockville, Md. (US); David Sacks, Silver Spring, Md. (US); and Jose M. C. Ribeiro, Rockville, Md. (US) | ||
Assigned to The United States of America as represented by the Department of Health and Human Services, Washington, D.C. (US) | ||
Appl. No. 10/481,180 PCT Filed Jun. 18, 2002, PCT No. PCT/US02/19663 § 371(c)(1), (2), (4) Date Dec. 17, 2003, PCT Pub. No. WO02/102324, PCT Pub. Date Dec. 27, 2002. |
||
Claims priority of provisional application 60/299391, filed on Jun. 19, 2001. | ||
Prior Publication US 2004/0171821 A1, Sep. 02, 2004 | ||
Int. Cl. C07H 21/04 (2006.01); C07H 21/02 (2006.01); C07K 14/00 (2006.01); A61K 38/00 (2006.01); C12P 21/04 (2006.01) |
U.S. Cl. 536—23.7 [536/23.1; 435/69.1; 435/69.7; 514/12; 424/184.1; 530/324; 530/334; 530/350] | 5 Claims |
1. An isolated salivary polypeptide of Phlebotomus papatasi, wherein the polypeptide consists of the amino acid sequence set forth as SEQ ID NO:12. |